Introduction {#sec1}
============

Pyridines are one of the most important *N*-containing heterocycles with applications in many fields^[@ref1]^ such as organic synthesis,^[@ref2]^ materials science,^[@ref3]^ and pharmaceutical science.^[@ref4]^ Currently, pyridine-based natural compounds continue to be discovered and studied for their properties and biosynthesis.^[@ref5]^ Within the pyridine family, 2,4,6-trisubstituted pyridines have garnered great attention because their excellent thermal stability^[@ref6]^ makes them excellent ligands for various metals.^[@ref7]^ For example, cyclometalated Au(III) complexes featuring a tridentate C\^N\^C scaffold have proven to be effective anticancer drugs ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, \[Au(Ph-C\^N\^C)Cl\]).^[@ref8]^ Moreover, 2,4,6-triarylpyridines are a class of G-quadruplex binding ligands that stabilize G-quadruplex DNA (G4-DNA) and provide an efficient approach to cancer treatment ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, G-quadruplex binding ligands).^[@ref9]^

![Structure of \[Au(Ph-C\^N\^C)Cl\] and G-quadruplex binding ligands.](ao-2019-00999s_0001){#fig1}

The traditional synthetic strategies toward the construction of 2,4,6-trisubstituted pyridines require three components, one of which is an additional nitrogen source.^[@ref10]^ Recently, simple two-component condensation reactions for the synthesis of 2,4,6-trisubstituted pyridines have been developed.^[@ref11]^ However, most of their starting materials, such as oximes^[@ref12]^ and chalcones,^[@ref13]^ are not commercially available. Benzylamines are considered efficient substrates for the synthesis of 2,4,6-trisubstituted pyridines and play a dual role of providing an aryl functionality at the 4-position of the pyridines as well as being a nitrogen source. The use of transition metal catalysts is one of the powerful methods to synthesize 2,4,6-triarylpyridines via the oxidative condensation reaction of benzylamines with acetophenones.^[@ref14]^ Moreover, metal-free versions of the reaction were recently reported, as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. Although these limited methods provide complementary pathways toward the synthesis of 2,4,6-triarylpyridines, corrosive trifluoromethanesulfonic acid (eq 1),^[@ref15]^ iodine at relatively high temperature (140 °C) (eq 2),^[@ref16]^ or complex photoredox catalyst eosin Y with a noncatalytic amount of BF~3~·Et~2~O (50 mol %) upon additional photoirradiation (eq 3)^[@ref17]^ were needed. Because of these disadvantages, development of a one-pot synthesis of drug candidates via the application of 2,4,6-triarylpyridines becomes difficult. In addition, their limited substrate scopes, especially difficulties with amino groups, make it impossible to apply these reactions to the synthesis of G-quadruplex binding ligands. Therefore, the development of metal-free, catalytic methods for 2,4,6-triarylpyridines synthesis is strongly desired.

![Synthesis of 2,4,6-Trisubstituted Pyridines](ao-2019-00999s_0002){#sch1}

We recently developed a metal-free method to oxidize benzylamines to imines using salicylic acid derivatives as organocatalysts, and successfully applied this efficient method to synthesize *N*-containing heterocycles and blue dyes.^[@ref18]^ Herein, we report an efficient protocol to synthesize 2,4,6-trisubstituted pyridines by the 4,6-dihydroxysalicylic acid-catalyzed oxidative condensation of benzylamines and acetophenones in the air, and the application of this method to the synthesis of G-quadruplex binding ligands in two steps ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, eq 4). Note that most of the previously reported procedures to synthesize G-quadruplex binding ligands require three or four steps; all of these procedures start from the three-component reaction of aldehydes, 4-aminoacetophenones, and nitrogen donors to obtain 2,4,6-triarylpyridines, followed by stepwise reaction of the isolated 2,4,6-triarylpyridines with 4-chlorobutyryl chloride and pyrrolidine.^[@ref9]^ To our delight, our present work provides the first example for the synthesis of G-quadruplex binding ligands starting from benzylamines and 4-aminoacetophenones. The resulting mixtures containing 2,4,6-triarylpyridines bearing amino groups were then allowed to react directly with 4-chlorobutyryl chlorides without an intermediate purification step. After a simple reaction workup, the residues were next reacted with pyrrolidines to successfully afford G-quadruplex binding ligands. Therefore, this metal-free method for the synthesis of 2,4,6-trisubstituted pyridines and G-quadruplex binding ligands is facile, efficient, and time-saving.

Results and Discussion {#sec2}
======================

To begin the study, 4,6-dihydroxysalicylic acid (2.5 mol %)^[@ref18]^ was employed as an organocatalyst, and 4-methoxyacetophenone (**2a**, 1.0 mmol) was chosen as the model substrate for condensation with benzylamine (**1a**, 0.5 mmol) under 0.1 MPa of O~2~ atmosphere (via an O~2~ balloon) at 100 °C for 24 h. A survey of different solvents (0.5 mL) suggested that dimethyl sulfoxide (DMSO) was the optimal solvent to afford 2,4,6-trisubstituted pyridine **4a** in 45% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1--7). Increasing the amount of **1a** up to 1.0 mmol resulted in the formation of **4a** in 56% yield under an O~2~ atmosphere (entry 8). Removing the O~2~ balloon and conducting the reaction in air slightly improved the yield of **4a** (entry 9). Therefore, we continued to optimize the reaction in air. A decrease in the amount of DMSO (0.1 mL) was favorable for the formation of **4a** (entry 10). BF~3~·Et~2~O was found to be an efficient additive for the reaction, and the loading of BF~3~·Et~2~O could be decreased to 10 mol % (entries 11--17). In the presence of BF~3~·Et~2~O (5 mol %), 1.0 mmol of **2a** could be coupled with 1.5 mmol of benzylamine to form **4a** in 77% yield (entry 13). Further increasing the amount of BF~3~·Et~2~O to 10 mol % promoted the formation of **4a** (79%, entry 14). A higher loading of 4,6-dihydroxysalicylic acid (5 mol %) gave **4a** in 81% yield, whereas an even higher loading (10 mol %) was not needed (entries 15--16). Using 5 mol % of 4,6-dihydroxysalicylic acid and increasing the amount of BF~3~·Et~2~O (20 mol %) hindered the reaction (entry 17). A large excess of benzylamine (3.0 mmol) gave a similar yield of **4a** (entry 18) to the reaction with less benzylamine (1.5 mmol, entry 15). The neat reaction was inefficient for the formation of **4a** (entry 19). The optimal conditions for the reaction were 4-methoxyacetophenone (**2a**, 1.0 mmol) and benzylamine (**1a**, 1.5 mmol) in the presence of 4,6-dihydroxysalicylic acid (5 mol %) as the organocatalyst and BF~3~·Et~2~O (10 mol %) as the additive at 100 °C for a short reaction time (18 h) in the air to form **4a** in 83% yield (entry 20). A shorter reaction time (12 h), lower temperature (80 °C), or higher temperature (120 °C) gave disappointing results (entries 21--23).

###### Optimization of Reaction Conditions for Synthesis of 2,4,6-Trisubstituted Pyridines[a](#t1fn1){ref-type="table-fn"}

![](ao-2019-00999s_0005){#GRAPHIC-d7e366-autogenerated}

  entry   *x*   *y*     solvent (mL)    additive (mmol)        atmosphere       yield[b](#t1fn2){ref-type="table-fn"} (%)
  ------- ----- ------- --------------- ---------------------- ---------------- -----------------------------------------------------------------------
  1       0.5   0.025   CH~3~OH (0.5)   none                   O~2~ (0.1 MPa)   5[c](#t1fn3){ref-type="table-fn"}
  2       0.5   0.025   CHCl~3~ (0.5)   none                   O~2~ (0.1 MPa)   8[c](#t1fn3){ref-type="table-fn"}
  3       0.5   0.025   CH~3~CN (0.5)   none                   O~2~ (0.1 MPa)   14[d](#t1fn4){ref-type="table-fn"}
  4       0.5   0.025   EtOAc (0.5)     none                   O~2~ (0.1 MPa)   16[d](#t1fn4){ref-type="table-fn"}
  5       0.5   0.025   toluene (0.5)   none                   O~2~ (0.1 MPa)   27
  6       0.5   0.025   DMF (0.5)       none                   O~2~ (0.1 MPa)   14
  7       0.5   0.025   DMSO (0.5)      none                   O~2~ (0.1 MPa)   45
  8       1.0   0.025   DMSO (0.5)      none                   O~2~ (0.1 MPa)   56
  9       1.0   0.025   DMSO (0.5)      none                   air              60
  10      1.0   0.025   DMSO (0.1)      none                   air              64
  11      1.0   0.025   DMSO (0.1)      BF~3~·Et~2~O (0.025)   air              69
  12      1.0   0.025   DMSO (0.1)      BF~3~·Et~2~O (0.05)    air              74
  13      1.5   0.025   DMSO (0.1)      BF~3~·Et~2~O (0.05)    air              77
  14      1.5   0.025   DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              79
  15      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              81
  16      1.5   0.1     DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              81
  17      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.2)     air              71
  18      3.0   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              82
  19      1.5   0.05    neat            BF~3~·Et~2~O (0.1)     air              70
  20      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              83 (81)[e](#t1fn5){ref-type="table-fn"}
  21      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              70[f](#t1fn6){ref-type="table-fn"}
  22      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              43[d](#t1fn4){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}
  23      1.5   0.05    DMSO (0.1)      BF~3~·Et~2~O (0.1)     air              67[e](#t1fn5){ref-type="table-fn"}^,^[g](#t1fn7){ref-type="table-fn"}

Conditions: **1a**, **2a**, **3**, additive, and solvent were stirred at 100 °C for 24 h.

Determined by ^1^H NMR using an internal standard of 1,3,5-trioxane (isolated yield).

Reaction temperature was 60 °C.

Reaction temperature was 80 °C.

Reaction time was 18 h.

Reaction time was 12 h.

Reaction temperature was 120 °C.

With the optimized reaction conditions in hand ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 20), the scope of the substrates was next investigated. A series of benzylamines were examined to couple with 4-methoxyacetophenone ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). More specifically, when benzylamines with a methyl substituent at the *ortho* and *para* positions were employed as substrates, the corresponding 2,4,6-triarylpyridines **4b--4c** were obtained in high yields. A methoxy substituent at the *ortho*, *meta*, and *para* positions of benzylamines underwent the condensation reaction with **2a** to give the desired products **4d--4f**. Benzylamines bearing other substituents, such as 4-*tert*-butyl, 3-chloro, and 4-chloro, were also examined under the standard reaction conditions, and 2,4,6-triarylpyridines **4g--4i** were formed in good to high yields. A strong electron-withdrawing group, 4-trifluoromethyl, resulted in a somewhat sluggish reaction for the formation of the product **4j**. In addition, several activated primary amines such as 1-naphthylmethylamine (**1k**), furfurylamine (**1l**), 2-pyridinemethylamine (**1m**), and 2-thiophenemethylamine (**1n**) were examined. 1-Naphthylmethylamine and 2-thiophenemethylamine could be successfully transformed into the corresponding 2,4,6-triarylpyridines **4k** and **4n**. Product **4k** in particular was obtained in excellent yield (91%). The reactions of furfurylamine and 2-pyridinemethylamine did not proceed well, probably because of the low conversion of amines to imines (**4l--4m**). When 2-pyridinemethylamine was employed, the competitive α-alkylation reaction of ketones resulted in a 32% yield of **6**. The gram-scale synthesis of 2,4,6-trisubstituted pyridines was also successful under the standard reaction conditions; 1.38 g (3.75 mmol, 75% isolated yield) of **4a** was obtained from 10 mmol of **2a** (1.5 g) after increasing the reaction time to 3 days.

###### Synthesis of 2,4,6-Trisubstituted Pyridines Using Various Benzylamines[a](#t2fn1){ref-type="table-fn"}

![](ao-2019-00999s_0006){#GRAPHIC-d7e1214-autogenerated}

![](ao-2019-00999s_0007){#gr5}

Yield of isolated product is based on **2a**.

Gram scale: **1a** (15 mmol), **2a** (10 mmol), **3** (0.5 mmol), BF~3~·Et~2~O (1.5 mmol), and DMSO (1.0 mL) were stirred together for 3 days.

The substrate scope was further investigated using a variety of acetophenone derivatives to couple with benzylamine under the optimized reaction conditions ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). First, acetophenone derivatives bearing methyl substituents at the *ortho*, *meta*, and *para* positions were examined and produced the corresponding 2,4,6-triarylpyridines **5b--5d** in moderate to good yields. It is believed that steric hindrance of the *ortho*-methyl group might be responsible for the reduced yield of **5b** (compare **5b** vs **5c** and **5d**). This situation also occurred in the reaction with *ortho*-methoxyacetophenone; **5e** was formed in a low yield, whereas the outcomes of the *meta*- and *para*-methoxy substituents were better (compare **5e** vs **5f** and [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, **4a**). The acetophenone derivative with a *para*-*tert*-butyl substituent gave the corresponding product **5g** in good yield. In contrast, acetophenone derivatives bearing electron-withdrawing groups such as *ortho*-chloro, *para*-chloro, *para*-bromo, *para*-iodo, and *para*-trifluoromethyl gave moderate yields of the products **5h--5l**. Activated ketones were also examined under the standard reaction conditions. The reaction of 2′-acetonaphthone afforded the corresponding 2,4,6-triarylpyridine **5m** in good yield. When 2-acetylfuran was employed, pyrrole derivative **7**, instead of **5n**, was formed via the Clauson-Kaas reaction of 2-acetylfuran and benzylamine. 2-Acetylthiophene tolerated the condensation reaction to afford **5o** in moderate yield, whereas the reaction of 2-acetylpyridine gave the product **5p** in a low yield. An aliphatic ketone was also examined under the optimized reaction conditions and gave an acceptable outcome (**5q**).

###### Synthesis of 2,4,6-Trisubstituted Pyridines Using Various Acetophenones[a](#t3fn1){ref-type="table-fn"}

![](ao-2019-00999s_0008){#GRAPHIC-d7e1360-autogenerated}

![](ao-2019-00999s_0009){#gr6}

Yield of the isolated product is based on **2**.

To gain insight into the reaction mechanism of this pyridine synthesis, several control experiments were conducted as shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} (eqs 5--10). As expected given our previous work,^[@ref18]^ benzylamine (**1a**) could be oxidized to imine **8** under the standard reaction conditions, and 10% of aldehyde **9** was also generated, most probably because of water from the air ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}, eq 5). Imine **8** was employed as substrate to couple with **2a** and afforded **4a** in 38% yield, whereas amine **10**, which could also be generated from benzylamine, failed to give the pyridine product (eqs 6 and 7). The use of imine **8** in combination with benzylamine (**1a**, 0.5 mmol) as substrates for reaction with **2a** provided **4a** in 73% yield (eq 8). These results suggested that an imine might be the intermediate for this pyridine synthesis, and that benzylamines play the dual role of providing the aryl moiety at the 4-position of the 2,4,6-trisubstituted pyridines as well as acting as the nitrogen donor. When the reaction of benzylamine (**1a**, 1.0 mmol), ketone (**2a**, 1.0 mmol), and 4-tolualdehyde (**11**, 1.0 mmol) was conducted under the standard reaction conditions, **4c** bearing a *para*-methyl-substituted pyridine was obtained in 49% yield, whereas only a trace of **4a** was formed (eq 9). This result might indicate that an aldehyde is the key intermediate for this pyridine synthesis. Then, the reaction of **1a**, **2a**, and **11** was also performed in argon atmosphere, and as a result, 49% of imine **12** was formed as the main product (eq 10). Compounds **13a** and **14**, which were speculated as the intermediates for this reaction, were also detected. Moreover, 7% of 2,4,6-trisubstituted pyridine **4c** was formed probably via the oxidation of 1,4-dihydropyridine **17** (vide infra) by a trace amount of oxygen in reagents. These results suggest that the nitrogen source for the formation of 2,4,6-trisubstituted pyridine is benzylamine.

![Control Experiments](ao-2019-00999s_0003){#sch2}

On the basis of these control experiments, a mechanism for the synthesis of 2,4,6-trisubstituted pyridines is proposed, as shown in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. In the presence of 4,6-dihydroxysalicylic acid, benzylamine (**1a**) can be oxidized to imine **8**.^[@ref18]^ Then, the hydrolysis of the imine may generate aldehyde **9** and **1a**, which is a reversible reaction. Promoted by BF~3~·Et~2~O, the keto--enol tautomerism of ketone **2a** gives enol **15**, which subsequently undergoes a condensation reaction with aldehyde **9** to afford the intermediate **13b**. Besides, the condensation of **2a** and **1a** forms the intermediate **14**, which transforms to **16** in the presence of BF~3~·Et~2~O. A further addition reaction occurs between **16** and **13b**, leading to the formation of 1,4-dihydropyridine **17**, which undergoes the oxidative aromatization to form the pyridine product **4a**.

![Possible Pathway for the Synthesis of 2,4,6-Trisubstituted Pyridines](ao-2019-00999s_0004){#sch3}

2,4,6-Triarylpyridines are a class of G-quadruplex binding ligands that stabilize G4-DNA, which is very important for the treatment of cancer.^[@ref9]^ Herein, we applied this metal-free synthetic method of pyridines to synthesize a series of G-quadruplex binding ligands by adding 4-chlorobutyryl chloride and pyrrolidine ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}). First, benzylamine (**1a**) was employed as the substrate, and the oxidative condensation reaction of **1a** with 4-aminoacetophenone (**2r**) was conducted. Then, 4-chlorobutyryl chloride was added directly into the reaction mixture and the mixture was stirred overnight (\>16 h) at 60 °C. The resulting dark mixture was then basified with a saturated NaHCO~3~ solution to obtain a dark oil, which was easily separated from the mixture by pouring out the water. The dark oil was then reacted with pyrrolidine overnight (\>16 h) at room temperature to successfully afford G-quadruplex binding ligand **18a** in 65% yield. Thereafter, a series of benzylamine derivatives were examined to synthesize G-quadruplex binding ligands. Benzylamines with electron-donating groups such as methyl, methoxy, and *tert*-butyl at the para positions afforded the corresponding ligands **18b--18d** in moderate yields. Benzylamines bearing electron-withdrawing groups such as *para*-chloro and *para*-trifluoromethyl also gave the G-quadruplex binding ligands **18e--18f** in satisfactory yields. 1-Naphthylmethylamine was also examined, and the product **18g** was successfully obtained. This method provides the first example for the synthesis of G-quadruplex binding ligands starting from benzylamines and 4-aminoactophenones. Compared with reported methods,^[@ref9]^ which all require three or four steps, this procedure is efficient and time-saving, only requiring two steps.

###### Synthesis of G-Quadruplex Binding Ligands Using Various Benzylamines[a](#t4fn1){ref-type="table-fn"}

![](ao-2019-00999s_0010){#GRAPHIC-d7e1602-autogenerated}

![](ao-2019-00999s_0011){#gr7}

Yield of the isolated product is based on **2r**.

Conclusions {#sec3}
===========

We have developed a metal-free and efficient method to synthesize 2,4,6-trisubstituted pyridines from benzylamines and acetophenones in the presence of 4,6-dihydroxysalicylic acid and boron trifluoride-diethyl etherate in air. During this pyridine synthesis, benzylamines play a dual role of providing the aryl moiety at the 4-position of the pyridines and acting as the nitrogen donor. 4,6-Dihydroxysalicylic acid acts as an organocatalyst for the oxidation of benzylamines to imines, which then undergo a hydrolysis reaction to generate aldehydes. Facilitated by boron trifluoride-diethyl etherate, the condensation reaction of aldehydes with acetophenones and benzylamines occurs, and the adducts are readily oxidized to afford 2,4,6-trisubstituted pyridines. This facile method can be applied to the synthesis of G-quadruplex binding ligands by using 4-aminoacetophenone as the substrate and subsequently adding 4-chlorobutyryl chloride and pyrrolidine to obtain the corresponding G-quadruplex binding ligands in moderate yields. In the drug discovery process, the synthetic methods that require metal catalysts may cause significant problems because of the metal residues in the products. To avoid metal contamination of the final products, development of metal-free synthetic methods is strongly desired. Further investigations of metal-free oxidations are currently underway.

Experimental Section {#sec4}
====================

General Remarks {#sec4.1}
---------------

Unless otherwise stated, all starting materials and additives were purchased from commercial sources and used without further purification. All solvents were distilled and degassed with nitrogen before use. ^1^H NMR spectra were recorded on a JEOL JNM-ECS400 (400 MHz) FT NMR system or JEOL JNM-ECX400 (400 MHz) FT NMR system in CDCl~3~ with (CH~3~)~4~Si as an internal standard. ^13^C NMR spectra were recorded on a JEOL JNM-ECX400 (100 MHz) FT NMR or JEOL JNM-ECS400 (100 MHz) FT NMR in CDCl~3~. IR spectra are reported in wave numbers (cm^--1^). Electron ionization (EI) mass spectra were obtained by employing double focusing mass spectrometers.

General Procedure for the Synthesis of 2,4,6-Trisubstituted Pyridines (**4**) {#sec4.2}
-----------------------------------------------------------------------------

The desired benzylamine derivative **1** (1.5 mmol), 4-methoxyacetophenone (**2a**, 150.18 mg, 1.0 mmol), 4,6-dihydroxysalicylic acid (**3**, 8.5 mg, 0.05 mmol), and DMSO (0.1 mL) were added to a round-bottom flask, and then BF~3~·Et~2~O (12.5 μL, 0.1 mmol) was added to the mixture. The reaction mixture was stirred at 100 °C for 18 h under air, then cooled to room temperature. The residue was purified by silica gel chromatography (eluent: hexane/ethyl acetate) to give **4**.

*2,6-Bis(4-methoxyphenyl)-4-phenylpyridine (****4a****)* \[CAS: 50553-98-5\].^[@ref17]^ Yellow solid, 149.2 mg, 81% (isolated yield), mp 131--132 °C (lit. mp 129--131 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.16 (d, *J* = 8.7 Hz, 4H), 7.78 (s, 2H), 7.74 (d, *J* = 6.9 Hz, 2H), 7.44--7.55 (m, 3H), 7.04 (d, *J* = 8.7 Hz, 4H), 3.89 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 157.1, 150.1, 139.5, 132.5, 129.2, 129.0, 128.5, 127.3, 115.9, 114.2, 55.5.

*2,6-Bis(4-methoxyphenyl)-4-(o-tolyl)pyridine (****4b****)* yellow solid, 156.6 mg, 82% (isolated yield), mp 121--122 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.13 (d, *J* = 8.7 Hz, 4H), 7.54 (s, 2H), 7.31--7.35 (m, 4H), 7.02 (d, *J* = 9.2 Hz, 4H), 3.88 (s, 6H), 2.35 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 156.4, 151.3, 140.2, 135.3, 132.4, 130.8, 129.4, 128.5, 128.4, 126.2, 118.1, 114.2, 55.5, 20.5; IR (KBr, ν/cm^--1^): 2933, 2841, 1596, 1539, 1514, 1422, 1394, 1233, 1173, 1030, 834, 825, 773, 764; HRMS (EI) *m*/*z*: calcd for C~26~H~23~NO~2~ \[M\]^+^, 381.1729; found, 381.1725.

*2,6-Bis(4-methoxyphenyl)-4-(p-tolyl)pyridine (****4c****)* \[CAS: 681443-63-0\].^[@ref19]^ Yellow solid, 154.8 mg, 81% (isolated yield), mp 133--134 °C (lit. mp 128--129 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.16 (d, *J* = 8.7 Hz, 4H), 7.76 (s, 2H), 7.64 (d, *J* = 8.2 Hz, 2H), 7.33 (d, *J* = 8.2 Hz, 2H), 7.03 (d, *J* = 8.7 Hz, 4H), 3.89 (s, 6H), 2.44 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 157.1, 150.0, 139.0, 136.5, 132.6, 129.9, 128.5, 127.1, 115.7, 114.2, 55.5, 21.4.

*4-(2-Methoxyphenyl)-2,6-bis(4-methoxyphenyl)pyridine (****4d****)* white solid, 153.9 mg, 77% (isolated yield), mp 122--123 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.13 (d, *J* = 8.7 Hz, 4H), 7.74 (s, 2H), 7.39--7.45 (m, 2H), 7.00--7.11 (m, 6H), 3.88 (s, 6H), 3.87 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.4, 156.7, 156.4, 147.8, 132.8, 130.6, 130.0, 128.9, 128.5, 121.2, 118.5, 114.1, 111.6, 55.8, 55.5; IR (KBr, ν/cm^--1^): 2948, 2845, 2835, 1607, 1576, 1544, 1545, 1494, 1456, 1422, 1394, 1280, 1242, 1173, 1028, 831, 759, 592; HRMS (EI) *m*/*z*: calcd for C~26~H~23~NO~3~ \[M\]^+^, 397.1678; found, 397.1673.

*4-(3-Methoxyphenyl)-2,6-bis(4-methoxyphenyl)pyridine (****4e****)* white solid, 161.5 mg, 81% (isolated yield), mp 133--135 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.16 (d, *J* = 8.6 Hz, 4H), 7.76 (s, 2H), 7.44 (t, *J* = 7.9 Hz, 1H), 7.32 (d, *J* = 7.7 Hz, 1H), 7.25--7.26 (m, 1H), 6.99--7.04 (m, 5H), 3.91 (s, 3H), 3.89 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 160.3, 157.1, 150.0, 141.0, 132.5, 130.2, 128.5, 119.7, 115.9, 114.2, 113.1, 55.6, 55.5; IR (KBr, ν/cm^--1^): 2940, 2845, 1598, 1576, 1545, 1515, 1486, 1422, 1393, 1287, 1252, 1233, 1205, 1169, 1053, 1021, 871, 834, 785, 699; HRMS (EI) *m*/*z*: calcd for C~26~H~23~NO~3~ \[M\]^+^, 397.1678; found, 397.1678.

*2,4,6-Tris(4-methoxyphenyl)pyridine (****4f****)* \[CAS: 33567-23-6\].^[@ref17]^ White solid, 159.6 mg, 80% (isolated yield), mp 131--133 °C (lit. mp 133--134 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.15 (d, *J* = 8.7 Hz, 4H), 7.73 (s, 2H), 7.69 (d, *J* = 8.7 Hz, 2H), 7.01--7.06 (m, 6H), 3.88 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 160.5, 157.1, 149.6, 132.6, 131.7, 128.5, 128.4, 115.4, 114.6, 114.2, 55.6, 55.5.

*4-(4-(Tert-butyl)phenyl)-2,6-bis(4-methoxyphenyl)pyridine (****4g****)* yellow solid, 167.8 mg, 79% (isolated yield), mp 123--124 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.15 (d, *J* = 8.7 Hz, 4H), 7.77 (s, 2H), 7.68 (d, *J* = 8.2 Hz, 2H), 7.54 (d, *J* = 8.2 Hz, 2H), 7.03 (d, *J* = 8.7 Hz, 4H), 3.89 (s, 6H), 1.39 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.6, 157.0, 152.3, 150.0, 136.6, 132.6, 128.5, 127.0, 126.2, 115.7, 114.2, 55.5, 34.9, 31.5; IR (KBr, ν/cm^--1^): 2970, 2348, 1607, 1539, 1514, 1461, 1427, 1307, 1240, 1174, 1034, 826, 592; HRMS (EI) *m*/*z*: calcd for C~29~H~29~NO~2~ \[M\]^+^, 423.2198; found, 423.2200.

*4-(3-Chlorophenyl)-2,6-bis(4-methoxyphenyl)pyridine (****4h****)* \[CAS: 2097002-94-1\].^[@cit10d]^ Yellow solid, 151.2 mg, 75% (isolated yield), mp 120--121 °C (lit. mp 122--125 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.15 (d, *J* = 8.6 Hz, 4H), 7.69--7.71 (m, 3H), 7.56--7.60 (m, 1H), 7.42--7.44 (m, 2H), 7.03 (d, *J* = 9.1 Hz, 4H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 157.3, 148.7, 141.3, 135.2, 132.2, 130.4, 128.9, 128.5, 127.4, 125.5, 115.6, 114.2, 55.5.

*4-(4-Chlorophenyl)-2,6-bis(4-methoxyphenyl)pyridine (****4i****)* \[CAS: 857500-67-5\].^[@ref19]^ Yellow solid, 160.6 mg, 80% (isolated yield), mp 123--124 °C (lit. mp 114--116 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.14 (d, *J* = 8.7 Hz, 4H), 7.71 (s, 2H), 7.65 (d, *J* = 8.7 Hz, 2H), 7.48 (d, *J* = 8.2 Hz, 2H), 7.03 (d, *J* = 8.7 Hz, 4H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 157.3, 148.9, 137.9, 135.1, 132.3, 129.4, 128.6, 128.5, 115.5, 114.2, 55.5.

*2,6-Bis(4-methoxyphenyl)-4-(4-(trifluoromethyl)phenyl)pyridine (****4j****)* white solid, 129.7 mg, 59% (isolated yield), mp 123--124 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.15 (d, *J* = 8.7 Hz, 4H), 7.81 (d, *J* = 8.2 Hz, 2H), 7.77 (d, *J* = 8.2 Hz, 2H), 7.73 (s, 2H), 7.03 (d, *J* = 8.7 Hz, 4H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.8, 157.3, 148.7, 143.1, 132.1, 130.9 (q, *J* = 32.5 Hz), 128.5, 127.7, 126.1 (q, *J* = 3.8 Hz), 124.2 (q, *J* = 272.8 Hz), 115.7, 114.2, 55.5; IR (KBr, ν/cm^--1^): 2934, 2829, 2363, 1607, 1545, 1514, 1429, 1391, 1328, 1246, 1175, 1113, 1071, 1020, 826, 579, 517; HRMS (EI) *m*/*z*: calcd for C~26~H~20~F~3~NO~2~ \[M\]^+^, 435.1446; found, 43.1445.

*2,6-Bis(4-methoxyphenyl)-4-(naphthalen-1-yl)pyridine (****4k****)* yellow solid, 189.5 mg, 91% (isolated yield), mp 119--120 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.16 (d, *J* = 8.7 Hz, 4H), 7.92--7.96 (m, 3H), 7.71 (s, 2H), 7.44--7.59 (m, 4H), 7.02 (d, *J* = 9.2 Hz, 4H), 3.87 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 156.6, 150.2, 138.5, 133.9, 132.3, 131.2, 128.8, 128.6, 128.5, 126.8, 126.7, 126.3, 125.7, 125.5, 118.8, 114.2, 55.5; IR (KBr, ν/cm^--1^): 2940, 2837, 2370, 1607, 1542, 1513, 1394, 1241, 1173, 1029, 834, 802, 780, 578; HRMS (EI) *m*/*z*: calcd for C~29~H~23~NO~2~ \[M\]^+^, 417.1729; found, 417.1730.

*4-(Furan-2-yl)-2,6-bis(4-methoxyphenyl)pyridine (****4l****)* light gray solid, 32.3 mg, 18% (isolated yield), mp 149--150 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.14 (d, *J* = 8.6 Hz, 4H), 7.81 (s, 2H), 7.57 (d, *J* = 1.8 Hz, 1H), 7.02 (d, *J* = 8.6 Hz, 4H), 6.94 (d, *J* = 3.2 Hz, 1H), 6.56 (q, *J* = 1.7 Hz, 1H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 157.1, 152.3, 143.6, 139.0, 132.4, 128.4, 114.1, 112.2, 111.7, 108.3, 55.5; IR (KBr, ν/cm^--1^): 2845, 1609, 1539, 1516, 1489, 1456, 1240, 1173, 1018, 832, 759, 579; HRMS (EI) *m*/*z*: calcd for C~23~H~19~NO~3~ \[M\]^+^, 357.1365; found, 357.1364.

*2′,6′-Bis(4-methoxyphenyl)-2,4′-bipyridine (****4m****)* yellow solid, 40.8 mg, 22% (isolated yield), mp 132--133 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.79 (d, *J* = 4.5 Hz, 1H), 8.21 (d, *J* = 9.1 Hz, 4H), 8.18 (s, 2H), 7.82--7.91 (m, 2H), 7.34--7.37 (m, 1H), 7.04 (d, *J* = 8.6 Hz, 4H), 3.89 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 157.3, 155.8, 150.2, 148.1, 137.2, 132.4, 128.6, 123.8, 121.2, 115.1, 114.1, 55.5; IR (KBr, ν/cm^--1^): 2363, 1609, 1514, 1471, 1394, 1291, 1249, 1175, 1030, 829, 785; HRMS (EI) *m*/*z*: calcd for C~24~H~20~N~2~O~2~ \[M\]^+^, 368.1525; found, 368.1525.

*2,6-Bis(4-methoxyphenyl)-4-(thiophen-2-yl)pyridine (****4n****)* \[CAS: 170634-00-1\]. Yellow solid, 143.1 mg, 77% (isolated yield), mp 172--173 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.13 (d, *J* = 9.1 Hz, 4H), 7.75 (s, 2H), 7.59 (dd, *J* = 3.6, 0.9 Hz, 1H), 7.42 (dd, *J* = 5.2, 1.1 Hz, 1H), 7.16 (dd, *J* = 5.0, 3.6 Hz, 1H), 7.03 (d, *J* = 8.6 Hz, 4H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.7, 157.3, 142.9, 142.4, 132.3, 128.5, 128.5, 126.8, 125.2, 114.2, 114.1, 55.5; IR (KBr, ν/cm^--1^): 2837, 1600, 1545, 1511, 1423, 1405, 1239, 1172, 1035, 835, 822, 710, 580; HRMS (EI) *m*/*z*: calcd for C~23~H~19~NO~2~S \[M\]^+^, 373.1136; found, 373.1130.

*1-(4-Methoxyphenyl)-3-(pyridin-2-yl)propan-1-one (****6****)* \[CAS: 343596-75-8\].^[@cit14a]^ Yellow solid, 78.6 mg, 32% (isolated yield), mp 50--51 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 8.52 (d, *J* = 4.5 Hz, 1H), 7.98 (d, *J* = 9.1 Hz, 2H), 7.59 (td, *J* = 7.7, 1.8 Hz, 1H), 7.25 (d, *J* = 7.7 Hz, 1H), 7.10 (dd, *J* = 7.2, 5.0 Hz, 1H), 6.92 (d, *J* = 8.6 Hz, 2H), 3.86 (s, 3H), 3.45 (t, *J* = 7.2 Hz, 2H), 3.22 (t, *J* = 7.5 Hz, 2H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 198.0, 163.6, 161.1, 149.4, 136.5, 130.5, 130.1, 123.5, 121.3, 113.8, 55.6, 37.7, 32.4.

General Procedure for the Synthesis of 2,4,6-Trisubstituted Pyridines (**5**) {#sec4.3}
-----------------------------------------------------------------------------

Benzylamine (**1a**, 160.74 mg, 1.5 mmol), the desired acetophenone derivative **2** (1.0 mmol), 4,6-dihydroxysalicylic acid (**3**, 8.5 mg, 0.05 mmol), and DMSO (0.1 mL) were added to a round-bottom flask, and then BF~3~·Et~2~O (12.5 μL, 0.1 mmol) was added to the mixture. The reaction mixture was stirred at 100 °C for 18 h under air, then cooled to room temperature. The residue was purified by silica gel chromatography (eluent: hexane/ethyl acetate) to give **5**.

*2,4,6-Triphenylpyridine (****5a****)* \[CAS: 580-35-8\].^[@ref17]^ white solid, 114.3 mg, 74% (isolated yield), mp 137--138 °C (lit. mp 136--137 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.21 (d, *J* = 8.2 Hz, 4H), 7.90 (s, 2H), 7.76 (d, *J* = 7.7 Hz, 2H), 7.43--7.56 (m, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.7, 150.3, 139.7, 139.2, 129.3, 129.2, 129.1, 128.9, 127.3, 127.3, 117.3.

*4-Phenyl-2,6-di-o-tolylpyridine (****5b****)* \[CAS: 816446-55-6\].^[@cit10f]^ White solid, 103.5 mg, 62% (isolated yield), mp 134--135 °C (lit. mp 129--130 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 7.72 (d, *J* = 6.8 Hz, 2H), 7.59 (s, 2H), 7.42--7.51 (m, 5H), 7.26--7.30 (m, 6H), 2.48 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.3, 148.9, 140.9, 138.6, 136.1, 130.8, 130.0, 129.3, 129.2, 128.4, 127.3, 126.0, 120.3, 20.8.

*4-Phenyl-2,6-di-m-tolylpyridine (****5c****)* \[CAS: 2040475-81-6\].^[@cit10f]^ White solid, 125.9 mg, 75% (isolated yield), mp 157--158 °C (lit. mp 132--135 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.01 (s, 2H), 7.97 (d, *J* = 8.2 Hz, 2H), 7.86 (s, 2H), 7.75 (d, *J* = 6.8 Hz, 2H), 7.45--7.55 (m, 3H), 7.40 (t, *J* = 7.5 Hz, 2H), 7.24--7.27 (m, 2H), 2.48 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.9, 150.2, 139.8, 139.3, 138.5, 129.93, 129.2, 129.1, 128.8, 128.0, 127.3, 124.5, 117.3, 21.8.

*4-Phenyl-2,6-di-p-tolylpyridine (****5d****)* \[CAS: 16112-41-7\].^[@cit10f]^ White solid, 130.4 mg, 78% (isolated yield), mp 160--161 °C (lit. mp 158--159 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.10 (d, *J* = 8.2 Hz, 4H), 7.83 (s, 2H), 7.73 (d, *J* = 7.2 Hz, 2H), 7.44--7.53 (m, 3H), 7.31 (d, *J* = 8.2 Hz, 4H), 2.42 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.5, 150.2, 139.4, 139.1, 137.0, 129.5, 129.2, 129.00, 127.3, 127.1, 116.7, 21.5.

*2,6-Bis(2-methoxyphenyl)-4-phenylpyridine (****5e****)* \[CAS: 1428423-32-8\].^[@cit10f]^ Yellow solid, 91.6 mg, 50% (isolated yield), mp 154--155 °C (lit. mp 153--154 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 7.99 (s, 2H), 7.95 (dd, *J* = 7.7, 1.8 Hz, 2H), 7.72 (d, *J* = 7.2 Hz, 2H), 7.49 (t, *J* = 7.5 Hz, 2H), 7.41--7.44 (m, 1H), 7.37 (td, *J* = 7.8, 1.4 Hz, 2H), 7.10 (t, *J* = 7.5 Hz, 2H), 7.02 (d, *J* = 8.6 Hz, 2H), 3.88 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.2, 156.1, 147.8, 139.6, 131.7, 129.9, 129.8, 129.1, 128.7, 127.5, 121.6, 121.2, 111.6, 55.9.

*2,6-Bis(3-methoxyphenyl)-4-phenylpyridine (****5f****)* \[CAS: 1333120-04-9\].^[@cit10f]^ Yellow solid, 127.2 mg, 69% (isolated yield), mp 65--67 °C (lit. mp 76--78 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 7.87 (s, 2H), 7.80 (s, 2H), 7.74 (t, *J* = 6.6 Hz, 4H), 7.40--7.54 (m, 5H), 7.00 (dd, *J* = 7.9, 2.0 Hz, 2H), 3.92 (s, 6H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 160.2, 157.3, 150.3, 141.2, 139.1, 129.8, 129.3, 129.1, 127.3, 119.7, 117.6, 114.9, 112.8, 55.5.

*2,6-Bis(4-(tert-butyl)phenyl)-4-phenylpyridine (****5g****)* \[CAS: 2070893-06-8\].^[@ref20]^ White solid, 157.0 mg, 75% (isolated yield), mp 155--157 °C (lit. mp 158--160 °C); ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 8.12 (d, *J* = 8.2 Hz, 4H), 7.83 (s, 2H), 7.72 (d, *J* = 7.7 Hz, 2H), 7.42--7.53 (m, 7H), 1.38 (s, 18H); ^13^C{^1^H} NMR (100 MHz, DMSO-*d*~6~): δ 157.6, 152.2, 150.0, 139.4, 137.1, 129.2, 129.0, 127.3, 127.0, 125.8, 116.7, 34.8, 31.5.

*2,6-Bis(2-chlorophenyl)-4-phenylpyridine (****5h****)* \[CAS: 2056081-58-2\].^[@cit12a]^ Yellow solid, 115.0 mg, 61% (isolated yield), mp 148--149 °C (lit. mp 147--149 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 7.88 (s, 2H), 7.73--7.76 (m, 4H), 7.44--7.54 (m, 5H), 7.33--7.41 (m, 4H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.3, 148.5, 139.4, 138.4, 132.4, 132.0, 130.3, 129.8, 129.3, 127.4, 127.2, 121.7.

*2,6-Bis(4-chlorophenyl)-4-phenylpyridine (****5i****)* \[CAS: 72666-43-4\].^[@cit12a]^ Light yellow solid, 121.3 mg, 64% (isolated yield), mp 190--192 °C (lit. mp 186--187 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.14 (d, *J* = 8.6 Hz, 4H), 7.87 (s, 2H), 7.72--7.74 (m, 2H), 7.48--7.57 (m, 7H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 156.5, 150.7, 138.8, 137.9, 135.4, 129.3, 129.1, 128.5, 127.3, 117.3.

*2,6-Bis(4-bromophenyl)-4-phenylpyridine (****5j****)* \[CAS: 74918-94-8\].^[@cit12a]^ Light yellow solid, 165.6 mg, 71% (isolated yield), mp 198--199 °C (lit. mp 195--197 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.07 (d, *J* = 8.6 Hz, 4H), 7.87 (s, 2H), 7.72--7.74 (m, 2H), 7.65 (d, *J* = 8.6 Hz, 4H), 7.49--7.56 (m, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 156.6, 150.8, 138.8, 138.4, 132.0, 129.4, 128.8, 127.3, 123.8, 117.3.

*2,6-Bis(4-iodophenyl)-4-phenylpyridine (****5k****)* \[CAS: 2103202-38-4\]. Yellow solid, 141.1 mg, 50% (isolated yield), mp 176--177 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 7.92 (d, *J* = 8.6 Hz, 4H), 7.83--7.86 (m, 6H), 7.72 (d, *J* = 6.8 Hz, 2H), 7.47--7.55 (m, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 156.7, 150.7, 138.9, 138.8, 138.0, 129.3, 128.9, 127.3, 117.3, 95.7; IR (KBr, ν/cm^--1^): 2348, 1601, 1558, 1544, 1506, 1411, 1004, 816, 762, 692; HRMS (EI) *m*/*z*: calcd for C~23~H~15~I~2~N \[M\]^+^, 558.9294; found, 558.9293.

*4-Phenyl-2,6-bis(4-(trifluoromethyl)phenyl)pyridine (****5l****)* \[CAS: 2056081-57-1\].^[@cit12a]^ Light yellow solid, 110.0 mg, 50% (isolated yield), mp 152--153 °C (lit. mp 152--154 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.30 (d, *J* = 8.2 Hz, 4H), 7.97 (s, 2H), 7.74--7.79 (m, 6H), 7.49--7.58 (m, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 156.4, 151.1, 142.7, 138.5, 131.3 (q, *J* = 32.5 Hz), 129.6, 129.4, 127.6, 127.3, 125.9 (q, *J* = 3.8 Hz), 124.3 (q, *J* = 271.8 Hz), 118.4.

*2,6-Di(naphthalen-2-yl)-4-phenylpyridine (****5m****)* \[CAS: 3557-63-9\].^[@cit14a]^ Yellow solid, 157.5 mg, 77% (isolated yield), mp 156--157 °C (lit. mp 156--157 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.66 (d, *J* = 0.9 Hz, 2H), 8.39 (dd, *J* = 8.6, 1.8 Hz, 2H), 8.01 (s, 2H), 7.98 (dd, *J* = 8.8, 3.4 Hz, 4H), 7.88 (t, *J* = 4.8 Hz, 2H), 7.77--7.79 (m, 2H), 7.46--7.56 (m, 7H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 157.6, 150.4, 139.2, 137.1, 133.9, 133.7, 129.3, 129.2, 128.9, 128.5, 127.8, 127.4, 126.6, 126.4, 125.1, 117.6.

*4-Phenyl-2,6-di(thiophen-2-yl)pyridine (****5o****)* \[CAS: 5562-59-4\].^[@cit14a]^ Yellow solid, 93.0 mg, 58% (isolated yield), mp 113--114 °C (lit. mp 108--110 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 7.68--7.71 (m, 6H), 7.47--7.54 (m, 3H), 7.42 (d, *J* = 4.1 Hz, 2H), 7.13--7.15 (m, 2H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 152.7, 150.3, 145.0, 138.7, 129.2, 128.1, 127.9, 127.2, 125.0, 115.2.

*4′-Phenyl-2,2':6′,2″-terpyridine (****5p****)* \[CAS: 58345-97-4\].^[@ref21]^ Brown solid, 44.5 mg, 29% (isolated yield), mp 203--204 °C (lit. mp 206--208 °C); ^1^H NMR (400 MHz, CDCl~3~): δ 8.72--8.74 (m, 4H), 8.67 (d, *J* = 8.2 Hz, 2H), 7.85--7.91 (m, 4H), 7.43--7.53 (m, 3H), 7.33--7.36 (m, 2H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 156.4, 156.1, 150.5, 149.3, 138.6, 137.0, 129.1, 129.0, 127.5, 123.9, 121.5, 119.1.

*2,6-Diphenethyl-4-phenylpyridine (****5q****)* \[CAS: 1428423-37-3\].^[@cit14a]^ Yellow solid, 49.0 mg, 27% (isolated yield), mp 120--121 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 7.49 (d, *J* = 7.7 Hz, 2H), 7.37--7.45 (m, 3H), 7.17--7.30 (m, 10H), 7.09 (s, 2H), 3.08--3.19 (m, 8H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 161.3, 149.1, 141.8, 138.9, 129.1, 128.9, 128.7, 128.5, 127.2, 126.1, 118.8, 40.3, 36.4.

*1-(1-Benzyl-1H-pyrrol-2-yl)ethan-1-one (****7****)* \[CAS: 100713-02-8\].^[@ref22]^ Brown oil, 51.9 mg, 26% (isolated yield); ^1^H NMR (400 MHz, CDCl~3~): δ 7.21--7.31 (m, 3H), 7.10 (d, *J* = 6.8 Hz, 2H), 7.00 (q, *J* = 2.0 Hz, 1H), 6.90 (t, *J* = 2.0 Hz, 1H), 6.18 (q, *J* = 2.1 Hz, 1H), 5.58 (s, 2H), 2.41 (s, 3H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 188.5, 138.4, 130.5, 130.5, 128.7, 127.5, 127.2, 120.5, 108.6, 52.7, 27.4; MS (EI) \[M\]^+^*m*/*z*: 199.

General Procedure for the Synthesis of G-Quadruplex Binding Ligands (**18**) {#sec4.4}
----------------------------------------------------------------------------

The desired benzylamine derivative **1** (1.5 mmol), 4-aminoacetophenone (**2r**, 135.17 mg, 1.0 mmol), 4,6-dihydroxysalicylic acid (**3**, 8.5 mg, 0.05 mmol), and DMSO (0.1 mL) were added to a 50 mL round-bottom flask, and then BF~3~·Et~2~O (12.5 μL, 0.1 mmol) was added to the mixture. The reaction mixture was stirred at 100 °C for 18 h under air, then cooled to 60 °C. 4-Chlorobutyryl chloride (2.0 mL) was added and the resulting mixture was stirred overnight (\>16 h) at 60 °C. The dark reaction mixture was cooled in an ice bath and basified to pH \> 7 with a saturated NaHCO~3~ solution (35 mL). A dark oil appeared and was separated from the mixture by pouring out the water. The dark oil was collected and dissolved in methanol (20 mL), concentrated by vacuum, and then pyrrolidine (1.0 mL) was added to the residue. The resulting dark mixture was stirred overnight (\>16 h) at room temperature and cooled in an ice bath. Saturated NaHCO~3~ solution (35 mL) was then added, and the mixture was stirred for 1 h. A gray solid appeared and was collected by filtration. The filter cake was dissolved in methanol/chloroform (30 mL, 1:4) and concentrated by vacuum. The residue was purified by preparative thin-layer chromatography (eluent: chloroform/methanol/triethylamine = 15/4/1) to give **18**.

*N,N'-((4-Phenylpyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18a****)* \[CAS: 1023617-87-9\].^[@cit9d]^ Dark yellow solid, 199.1 mg, 65% (isolated yield), mp 123--125 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.95 (br, 2H), 8.16 (d, *J* = 8.7 Hz, 4H), 7.81 (s, 2H), 7.73 (d, *J* = 7.8 Hz, 2H), 7.68 (d, *J* = 8.2 Hz, 4H), 7.44--7.54 (m, 3H), 2.67--2.68 (m, 12H), 2.57 (t, *J* = 6.4 Hz, 4H), 1.90--1.96 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.8, 156.8, 150.1, 139.8, 139.1, 134.9, 129.1, 129.0, 127.7, 127.2, 119.7, 116.2, 55.8, 54.0, 36.7, 23.9, 23.6.

*N,N'-((4-(p-Tolyl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18b****)* dark yellow solid, 188.0 mg, 60% (isolated yield), mp 102--104 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.93 (br, 2H), 8.14 (d, *J* = 8.7 Hz, 4H), 7.78 (s, 2H), 7.66 (d, *J* = 8.2 Hz, 4H), 7.62 (d, *J* = 7.8 Hz, 2H), 7.31 (d, *J* = 7.8 Hz, 2H), 2.64--2.65 (m, 12H), 2.55 (t, *J* = 6.4 Hz, 4H), 2.43 (s, 3H), 1.87--1.96 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.9, 156.7, 149.9, 139.7, 139.0, 136.0, 134.9, 129.8, 127.6, 126.9, 119.7, 115.9, 55.8, 54.0, 36.7, 24.0, 23.6, 21.3; IR (KBr, ν/cm^--1^): 2956, 2800, 1661, 1600, 1516, 1423, 1387, 1246, 1181, 811; HRMS (EI) *m*/*z*: calcd for C~40~H~47~N~5~O~2~ \[M\]^+^, 629.3730; found, 629.3729.

*N,N'-((4-(4-Methoxyphenyl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18c****)* dark yellow solid, 199.3 mg, 62% (isolated yield), mp 99--101 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.94 (br, 2H), 8.14 (d, *J* = 8.2 Hz, 4H), 7.76 (s, 2H), 7.67 (t, *J* = 8.0 Hz, 6H), 7.03 (d, *J* = 8.2 Hz, 2H), 3.88 (s, 3H), 2.53--2.64 (m, 16H), 1.87--1.94 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 172.0, 160.4, 156.6, 149.4, 139.6, 134.9, 131.2, 128.2, 127.6, 119.7, 115.6, 114.5, 55.8, 55.4, 54.0, 36.7, 24.1, 23.6; IR (KBr, ν/cm^--1^): 2933, 2791, 1668, 1602, 1511, 1429, 1390, 1253, 1178, 1117, 1028, 828; HRMS (EI) *m*/*z*: calcd for C~40~H~47~N~5~O~3~ \[M\]^+^, 645.3679; found, 645.3674.

*N,N'-((4-(4-(Tert-butyl)phenyl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18d****)* dark yellow solid, 184.0 mg, 55% (isolated yield), mp 113--115 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.94 (br, 2H), 8.16 (d, *J* = 8.7 Hz, 4H), 7.81 (s, 2H), 7.67 (t, *J* = 8.9 Hz, 6H), 7.55 (d, *J* = 8.2 Hz, 2H), 2.64--2.67 (m, 12H), 2.56 (t, *J* = 6.4 Hz, 4H), 1.89--1.95 (m, 12H), 1.39 (s, 9H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.9, 156.8, 152.3, 150.0, 139.7, 136.2, 135.0, 127.7, 126.9, 126.1, 119.7, 116.2, 55.9, 54.1, 37.1, 34.8, 31.4, 24.0, 23.7; IR (KBr, ν/cm^--1^): 2955, 1684, 1602, 1516, 1423, 1387, 1253, 1180, 1113, 830; HRMS (EI) *m*/*z*: calcd for C~43~H~53~N~5~O~2~ \[M\]^+^, 671.4199; found, 671.4194.

*N,N'-((4-(4-Chlorophenyl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18e****)* dark yellow solid, 188.3 mg, 58% (isolated yield), mp 94--96 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.98 (br, 2H), 8.15 (d, *J* = 8.7 Hz, 4H), 7.76 (s, 2H), 7.67 (d, *J* = 7.3 Hz, 6H), 7.49 (d, *J* = 8.2 Hz, 2H), 2.66--2.67 (m, 12H), 2.57 (t, *J* = 6.4 Hz, 3H), 1.90--1.94 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.9, 156.9, 148.8, 139.9, 137.5, 135.1, 134.7, 129.3, 128.5, 127.7, 119.7, 115.9, 55.9, 54.1, 36.8, 24.0, 23.7; IR (KBr, ν/cm^--1^): 2934, 2791, 1601, 1516, 1423, 1386, 1252, 1179, 1093, 1014, 823; HRMS (EI) *m*/*z*: calcd for C~39~H~44~ClN~5~O~2~ \[M\]^+^, 649.3184; found, 649.3188.

*N,N'-((4-(4-(Trifluoromethyl)phenyl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18f****)* dark yellow solid, 187.3 mg, 55% (isolated yield), mp 105--107 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 10.00 (br, 2H), 8.16 (d, *J* = 8.7 Hz, 4H), 7.77--7.84 (m, 6H), 7.68 (d, *J* = 8.2 Hz, 4H), 2.55--2.68 (m, 16H), 1.90--1.96 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 172.0, 157.1, 148.7, 142.7, 140.0, 134.5, 130.9 (q, *J* = 32.7 Hz), 127.7, 127.6, 126.1 (q, *J* = 3.8 Hz), 124.1 (q, *J* = 272.1 Hz), 119.8, 116.1, 55.9, 54.1, 36.9, 24.0, 23.7; IR (KBr, ν/cm^--1^): 2956, 2800, 2356, 1653, 1601, 1516, 1387, 1324, 1165, 1123, 1067, 1016, 835; HRMS (EI) *m*/*z*: calcd for C~40~H~44~F~3~N~5~O~2~ \[M\]^+^, 683.3447; found, 683.3445.

*N,N'-((4-(Naphthalen-1-yl)pyridine-2,6-diyl)bis(4,1-phenylene))bis(4-(pyrrolidin-1-yl)butanamide) (****18g****)* brown solid, 173.3 mg, 52% (isolated yield), mp 115--117 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 9.95 (br, 2H), 8.17 (d, *J* = 8.2 Hz, 4H), 7.94 (d, *J* = 8.2 Hz, 3H), 7.76 (s, 2H), 7.66 (d, *J* = 8.7 Hz, 4H), 7.46--7.60 (m, 4H), 2.54--2.65 (m, 16H), 1.88--1.95 (m, 12H); ^13^C{^1^H} NMR (100 MHz, CDCl~3~): δ 171.8, 156.4, 150.2, 139.8, 138.2, 134.8, 133.9, 131.1, 128.8, 128.6, 127.8, 126.8, 126.7, 126.2, 125.5, 119.7, 119.4, 55.9, 54.1, 37.0, 24.0, 23.7; IR (KBr, ν/cm^--1^): 2963, 2807, 1652, 1600, 1516, 1418, 1247, 1179, 842, 777; HRMS (EI) *m*/*z*: calcd for C~43~H~47~N~5~O~2~ \[M\]^+^, 665.3730; found, 665.3731.

General Procedure for the Gram-Scale Synthesis of 2,6-Bis(4-methoxyphenyl)-4-phenylpyridine (**4a**) {#sec4.5}
----------------------------------------------------------------------------------------------------

Benzylamine (**1a**, 1.6 g, 15 mmol), 4-methoxyacetophenone (**2a**, 1.5 g, 10 mmol), 4,6-dihydroxysalicylic acid (**3**, 85 mg, 0.5 mmol), and DMSO (1.0 mL) were added to a round-bottom flask, and then BF~3~·Et~2~O (187.5 μL, 1.5 mmol) was added to the mixture. The reaction mixture was stirred at 100 °C for 3 days under air, then cooled to room temperature. The residue was purified by silica gel chromatography (eluent: hexane/ethyl acetate) to give **4a** (1.38 g).
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